This program funds research to identify genetic, genomic, and epigenetic variants underlying addictive behaviors, substance use disorder stages, and related comorbidities. It supports studies employing genomics, multi-omics, and neuroscience approaches to uncover novel mechanisms and therapeutic targets for addiction. Applications may analyze various genomic variants and integrate multi-level omics data to delineate gene networks and functions relevant to addiction biology.
Eligible applicants include Native American tribal governments and organizations, educational institutions, state and local governments, nonprofits, and for-profit organizations including small businesses. See official guidelines for full details.
